Injectable Silicone Shows Promisefor Treatment of HIV-associated Facial Lipoatrophy

Chicago -- Off-label experience using injectable silicone (Silikon 1000) in an investigational protocol indicates it is a highly effective and, thus far, very safe modality for treating facial lipoatrophy in HIV-infected patients, Derek H. Jones, M.D., said at the annual meeting of the American Society for Dermatologic Surgery.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.